PEOPLE - Targeted Diagnostics & Therapeutics (TDT) makes appointment:
This article was originally published in Clinica
Executive Summary
Targeted Diagnostics & Therapeutics (TDT), developer of molecular-based technologies for the targeted detection, diagnosis and treatment of gastrointestinal cancers and infectious diseases, has appointed Daniel O'Shannessy to the newly-created position of COO. He will be responsible for directing the West Chester, Pennsylvania-based firm's clinical and business expansion, as well as overseeing the strategic growth of new products and technologies. Dr O'Shannessy joins TDT from Gen-Probe, where he served as senior director of strategic planning for the oncology diagnostics division.